Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute leukemia in children

P S Gaynon1

  • 1University of Wisconsin Medical Center, Madison, USA.

Current Opinion in Hematology
|July 1, 1995
PubMed
Summary

Childhood leukemia, a significant childhood cancer, sees improving outcomes for acute lymphoblastic leukemia and potential advancements for acute nonlymphoblastic leukemia. New technologies aid in detecting minimal disease and predicting treatment success.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

Leukemia·2014
Same author

Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.

Leukemia·2014
Same author

The principle and practice of reinduction therapy (in ALL): repetita iuvant!

Klinische Padiatrie·2013
Same author

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Leukemia·2009
Same author

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.

Leukemia·2008
Same author

High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative.

Leukemia·2005

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Cancer Research

Background:

  • Childhood leukemia accounts for a third of pediatric cancers.
  • Incidence of acute lymphoblastic leukemia is rising, with improving outcomes.
  • Advancements offer hope for acute nonlymphoblastic leukemia treatment.

Purpose of the Study:

  • To review current understanding and future directions in childhood leukemia.
  • To highlight technological advancements in diagnosis and prognosis.
  • To discuss novel therapeutic strategies and long-term survivor care.

Main Methods:

  • Review of current literature and technological advancements.
  • Discussion of diagnostic techniques like submicroscopic bone marrow involvement detection.
  • Exploration of prognostic indicators such as in vitro chemosensitivity and molecular assays.

Main Results:

  • Submicroscopic disease detection is possible in certain remission or relapse cases.
  • In vitro chemosensitivity assays can predict patient outcomes.
  • Polymerase chain reaction-based assays provide prognostic significance for residual disease.

Conclusions:

  • Early detection and precise monitoring of minimal residual disease are crucial.
  • Novel therapeutic targets, like 6-thioguanine nucleotide accumulation, show promise.
  • Long-term health of survivors requires increased clinical attention for improved cure rates.

Related Experiment Videos